{
event: "article_read",
name: `556/146 for Lipid Management after ACS`,
author: ``,
tags: `Cardiovascular`,
publication_date: ``,
interaction_type: "content"
}
556/146 for Lipid Management after ACS
for Lipid Management after ACS
Gain deeper insights into the innovative concept of 556/146, this project aligns with the ESC/EAS 2019 dyslipidemia guidelines, which recommend that post-ACS (Acute Coronary Syndrome) patients achieve an LDL-C value of less than 55 mg/dL (1.4 mmol/L). Lipid levels should be reassessed 4-6 weeks after an ACS event, and if the target is not met, lipid-lowering treatments should be adjusted accordingly.
Through four comprehensive video episodes, we will explore the importance of these targets and the steps necessary to achieve them.
Episode #1
A video explaining the concept of 556/146. Featuring all 3 experts: Prof. A. Catapano, Prof. F. Schiele, Prof. A. Zaman.
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.